| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919498 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Our experience showed that a margin-directed policy of RT boost dose-escalation seems to reduce the negative impact of FMS on LR, but it is not able to overcome the unfavorable effect of higher nuclear grade, higher T stage and triple negative subtype.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lorenzo Livi, Icro Meattini, Davide Franceschini, Calogero Saieva, Fiammetta Meacci, Livia Marrazzo, Elena Gerlain, Isacco Desideri, Vieri Scotti, Jacopo Nori, Luis Jose Sanchez, Lorenzo Orzalesi, Pierluigi Bonomo, Daniela Greto, Simonetta Bianchi,